NuvaRing Lawyers to Meet with Court About Schedule for First Trials

Lawyers involved in the federal NuvaRing litigation, which includes hundreds of cases filed on behalf of women who allege that they suffered blood clot-related injuries after using the popular birth control ring, are scheduled to meet this week with the judge coordinating pretrial proceedings in the multidistrict litigation (MDL). It is expected that the parties will discuss scheduling of the first “bellwether” trials, which will help gauge how juries will respond to evidence that will be presented in different lawsuits over NuvaRing.

All of the cases involve similar allegations that Organon Pharmaceuticals failed to adequately research their birth control ring or warn that potential side effects of NuvaRing may increase the risk of a blood clot, pulmonary embolism, deep vein thrombosis (DVT), stroke, heart attack or sudden death.

There are currently about 250 cases from federal district courts throughout the United States that have been consolidated into the MDL in the U.S. District Court for the Eastern District of Missouri before District Judge Rodney W. Sipple. In addition, NuvaRing lawyers are continuing to review and investigate potential cases for users of the birth control ring, and it is expected that the number of cases filed will increase dramatically in the coming months.

Learn More About

NuvaRing Lawsuits

Side effects of NuvaRing may increase risk of blood clots, pumonary embolism, DVT, death. Lawsuits pending.

Learn More About this Lawsuit SEE IF YOU QUALIFY FOR COMPENSATION

In an order issued last month, Judge Sippel asked attorneys for plaintiffs and defendants to select 16 NuvaRing lawsuits each to go into a pool of potential bellwether cases for the first phase of the litigation. These cases will undergo additional case-specific discovery so that they can serve as early trials, which will help the parties determine the strengths or weaknesses of their cases, and potentially lead to a NuvaRing settlement or other resolution of the litigation.

Lawyers are set to meet with the court for a scheduling conference on Thursday to set dates for the completion and discovery and to set initial trial dates for the “Phase One” cases. The Court will also address discovery issues for the remaining cases in the MDL and a deposition protocol.

Another scheduling conference has been set for January 4, 2011, to establish deadlines for expert and dispositive motions in the “Phase One” cases.

Image Credit: |

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Gardasil Lawsuits Over Failure To Warn Doctors About HPV Vaccine Risks Cleared To Move Forward
Gardasil Lawsuits Over Failure To Warn Doctors About HPV Vaccine Risks Cleared To Move Forward (Posted today)

A federal judge has cleared Gardasil lawsuits to move forward, after paring down plaintiffs' claims to those alleging Merck either failed to warn, or fraudulently concealed, the HPV vaccine's risks from the medical community.